CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
3.320
+0.150 (4.73%)
At close: Aug 4, 2026, 4:00 PM EDT
3.374
+0.054 (1.62%)
Pre-market: Aug 5, 2026, 8:55 AM EDT
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $722.77 million as of August 5, 2026. Its market cap has increased by 281.41% in one year.
Market Cap
722.77M
Enterprise Value
378.92M
1-Year Change
281.41%
Ranking
Category
Stock Price
$3.32
ChartMarket Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from $7.40M to $722.77M, an increase of 9,667.21%. That is a compound annual growth rate of 52.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 722.77M | 0.13% |
| Dec 31, 2025 | 721.80M | 795.53% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 10,059.46% |
| Oct 8, 2015 | 7.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Candel Therapeutics | 770.07M |
| Bright Minds Biosciences | 762.47M |
| Pharming Group | 737.37M |
| AgomAb Therapeutics NV | 725.42M |
| Oculis Holding AG | 724.05M |
| Climb Bio | 719.19M |
| Rigel Pharmaceuticals | 716.03M |
| BridgeBio Oncology Therapeutics | 710.55M |